To a specific signal pathway, ligand LAMC1 with its receptor CD44 was active from the high-risk UPPRS myeloma cells to the rest of the cell types, and ligand–receptor pair HLA-DMA-CD4 was also found to increase from high-risk UPPRS myeloma cells to monocytes. This evidence concerns the gene CD4 and plasma cell myeloma.